MedTrace Logo

Adolescent Idiopathic Scoliosis (AIS) Gold Standard for Blood Loss

NCT03990376 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-06-11

No results posted yet for this study

Summary

The purpose of this study is to establish a benchmark for measuring blood loss by directly measuring the change in red cell volume before and after surgery and to compare established blood loss estimators to this benchmark in order to determine the most accurate and precise method for estimating blood loss in adolescent idiopathic scoliosis surgery patients

Conditions

  • Adolescent Idiopathic Scoliosis

Interventions

OTHER

Radioisotope I-131-labeled albumin

1 mL of radioisotope I-131-labeled albumin x 2

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Nicholas Fletcher · Emory University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-19
Primary Completion
2020-09-10
Completion
2020-09-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03990376 on ClinicalTrials.gov